Pricing Log in Create free account
Friday 6 November 2026 Export ICLR’s income statement to Excel — free account

ICON PLC

ICLR Healthcare Diagnostics & Research

ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.

Revenue
−2.86%
EPS
+143.2%
Free cash flow
−8.01%
Total debt
−0.86%

Quarter to September 2026, against a year earlier

201.62 1.49 −0.73%
Market cap
$15.1B
P/E
34.5×
Fwd P/E
34.6×
Dividend yield
—
F-score
6/9
Altman Z
2.01
Beneish M
−2.62
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

ICON PLC (ICLR) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, ICON PLC (ICLR) trades at a EV/Sales of 2.4×. Over the past ten years it has ranged from 1.1× (February 2026) to 6.9× (December 2021); the current reading is higher than 16% of that period. That is below the Diagnostics & Research industry median of 5.2× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.1× (16.19%)
FY2024 2.5× (24.33%)
FY2023 3.3× 25.16%
FY2022 2.6× (43.99%)
FY2021 4.6× 32.12%
FY2020 3.5× 8.04%
FY2019 3.3× 16.76%
FY2018 2.8× (24.99%)
FY2017 3.7× 35.65%
FY2016 2.7× (14.95%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.1× 7.84%
Jun 2026 1.9× 41.95%
Mar 2026 1.3× (34.99%)
Dec 2025 2.1× 1.37%
43 more quarters

Against its own ten years

Low 1.1× High 6.9×
Ten-year median 3.0×
Current reading's percentile 16

EV/Sales against peers

Company EV/Sales
ICLR ICON PLC 2.4×
LH Labcorp Holdings Inc. compare 2.4×
DGX Quest Diagnostics Incorporated compare 2.8×
CRL Charles River Laboratories International, Inc. compare 4.3×
QGEN QIAGEN N.V. compare 5.4×
MEDP Medpace Holdings, Inc. compare 6.0×
RVTY Revvity Inc. compare 6.6×
ILMN Illumina, Inc. compare 7.2×
GH Guardant Health, Inc. compare 16.6×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ICLR